Tigertriever 17 Ultra Revascularization Device
Ref TRPP3266
Expiring
CE MDR
Valid until
9 Jun 2027
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number1000313628 | Date11 Sep 2026 | StatusExpiring |
Certificates
- 1000313628 Expiring
Technical documentation EU MDR
- Certifier
- DQS Medizinprodukte GmbH 0297
- Issued
- 11 Sep 2026
- Expires
- 9 Jun 2027
- Reason
- Add device or group
- 1000313629 Expiring
Quality management system EU MDR
- Certifier
- DQS Medizinprodukte GmbH 0297
- Issued
- 11 Sep 2026
- Expires
- 9 Jun 2027
- Reason
- Add device or group
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Expiring
Specification
- Device Name
- Tigertriever Revascularization Device
- Model / Reference
- TRPP3266
- Primary DI / UDI-DI
- 07290015107389
- Basic UDI-DI
- 7290015107TRPP13C
- Direct Marketing DI
- 07290015107389
- EMDN Code
- C019010 Intravascular recanalisation systems
- Device Class
- Class III
- EU market of registration
- Germany
Manufacturer details
- EUDAMED SRN
- IL-MF-000012181
- Authorised representative
- MedNet EC-REP III GmbH DE-AR-000011191
Other devices from Rapid Medical Ltd
Properties
Other properties (12)
- Implantable: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No